Q4 2013 13F Holders as of 31 Dec 2013
-
Type / Class
-
Equity / ORD SHS
-
Total 13F shares
-
9,339,999
-
Share change
-
+131,220
-
Total reported value
-
$181,000,757
-
Price per share
-
$19.38
-
Number of holders
-
41
-
Value change
-
+$2,543,000
-
Number of buys
-
1
Institutional Holders of OXFORD IMMUNOTEC GLOBAL PLC - ORD SHS (OXFD) as of Q4 2013
As of 31 Dec 2013,
OXFORD IMMUNOTEC GLOBAL PLC - ORD SHS (OXFD) was held by
41 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
9,339,999 shares.
The largest 10 holders included
Clarus Ventures, LLC, Redmile Group, LLC, PRICE T ROWE ASSOCIATES INC /MD/, Invesco Ltd., LANSDOWNE PARTNERS LIMITED PARTNERSHIP, Fosun International Ltd, Alyeska Investment Group, L.P., Dow Chemical Co /DE/, BlackRock Advisors LLC, and Polar Capital LLP.
This page lists
41
institutional shareholders reporting positions in this security
for the Q4 2013 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.